Liver Cancer Stem Cells

Por Mikhail, Sameh, He, Aiwu Ruth
Publicado em 2011

A STORM in a teacup?—the challenges of adjuvant therapy in hepatocellular carcinoma (HCC)

Por Shetty, Kirti, He, Aiwu Ruth
Publicado no Transl Gastroenterol Hepatol (2016)

Workup and Management of Immune‐Mediated Hepatobiliary Pancreatic Toxicities That Develop During Immune Checkpoint Inhibitor Treatment

Por Hsu, Christine, Marshall, John L., He, Aiwu Ruth
Publicado no Oncologist (2019)

Workup and Management of Immune‐Mediated Colitis in Patients Treated with Immune Checkpoint Inhibitors

Por Singh, Bhavana Pendurthi, Marshall, John L., He, Aiwu Ruth
Publicado no Oncologist (2019)

Systemic therapy for advanced hepatocellular carcinoma: an update

Por Desai, Jasmin Radhika, Ochoa, Sebastian, Prins, Petra Alexandra, He, Aiwu Ruth
Publicado no J Gastrointest Oncol (2017)

Stem Cells in Gastrointestinal Cancers

Por He, Aiwu Ruth, Mendelson, Jonathan, Blake, Tiffany, Mishra, Lopa, Marshall, John L.
Publicado em 2008

Outcomes and Predictors of Toxicity after Selective Internal Radiation Therapy Using Yttrium-90 Resin Microspheres for Unresectable Hepatocellular Carcinoma

Por Gabrielson, Andrew, Miller, Akemi, Banovac, Filip, Kim, Alexander, He, Aiwu Ruth, Unger, Keith
Publicado no Front Oncol (2015)

Systemic Treatment for Advanced Hepatocellular Carcinoma

Por Bouattour, Mohamed, Mehta, Neil, He, Aiwu R., Cohen, Emil I., Nault, Jean-Charles
Publicado no Liver Cancer (2019)

Evaluation of Hypertension as a Marker of Bevacizumab Efficacy

Por Wu, Rebekah Ryanne, Lindenberg, Peter A., Slack, Rebecca, Noone, Anne-Michelle, Marshall, John L., He, Aiwu R.
Publicado em 2009

Yttrium-90 Radioembolization in Patients with Hepatocellular Carcinoma Who have Previously Received Sorafenib

Por Rana, Nitesh, Ju, Andrew Wenhua, Bazylewicz, Michael, Kallakury, Bhaskar, He, Aiwu Ruth, Unger, Keith R., Lee, Justin S.
Publicado em 2013

Synergistic Inhibition of Hepatocellular Carcinoma Growth by Cotargeting Chromatin Modifying Enzymes and Poly (ADP-ribose) Polymerases

Por Zhang, Jun-Xiang, Li, Da-Qiang, He, Aiwu Ruth, Motwani, Mona, Vasiliou, Vasilis, Eswaran, Jeyanthy, Mishra, Lopa, Kumar, Rakesh
Publicado em 2012

Liver Stem Cells and Hepatocellular Carcinoma

Por Mishra, Lopa, Banker, Tanuj, Murray, Joseph, Byers, Stephen, Thenappan, Arun, He, Aiwu Ruth, Shetty, Kirti, Johnson, Lynt, Reddy, E. P.
Publicado em 2009

Maintenance Therapy With Capecitabine in Patients With Resected Pancreatic Adenocarcinoma After Adjuvant Therapy: A Retrospective Cohort Study

Por Weinberg, Benjamin A., Wang, Hongkun, Yang, Xuezhong, Wu, Christina S., Pishvaian, Michael J., He, Aiwu R., Marshall, John L., Hwang, Jimmy J.
Publicado em 2014

A Phase I Study of Ribociclib Plus Everolimus in Patients with Metastatic Pancreatic Adenocarcinoma Refractory to Chemotherapy

Por Weinberg, Benjamin A., Wang, Hongkun, Witkiewicz, Agnieszka K., Marshall, John L., He, Aiwu R., Vail, Paris, Knudsen, Erik S., Pishvaian, Michael J.
Publicado no J Pancreat Cancer (2020)

Detection of a lipid peroxidation-induced DNA adduct across liver disease stages

Por Coia, Heidi, Ma, Ning, He, Aiwu Ruth, Kallakury, Bhaskar, Berry, Deborah L., Permaul, Eva, Makambi, Kepher H., Fu, Ying, Chung, Fung-Lung
Publicado no Hepatobiliary Surg Nutr (2018)

Phase II study of temozolomide and veliparib combination therapy for sorafenib-refractory advanced hepatocellular carcinoma

Por Gabrielson, Andrew, Tesfaye, Anteneh A., Marshall, John L., Pishvaian, Michael J., Smaglo, Brandon, Jha, Reena, Dorsch-Vogel, Karen, Wang, Hongkun, He, Aiwu Ruth
Publicado no Cancer Chemother Pharmacol (2015)

A phase I study of HER1, HER2 dual kinase inhibitor lapatinib plus the proteasome inhibitor bortezomib in patients with advanced malignancies

Por Lynce, Filipa, Wang, Hongkun, Petricoin, Emanuel F., Pohlmann, Paula R., Smaglo, Brandon, Hwang, Jimmy, He, Aiwu R., Subramaniam, Deepa, Deeken, John, Marshall, John, Pishvaian, Michael J.
Publicado no Cancer Chemother Pharmacol (2019)

A Phase I Study of Cetuximab and Lapatinib In Patients with Advanced Solid Tumor Malignancies

Por Deeken, John F., Wang, Hongkun, Subramaniam, Deepa, He, Aiwu Ruth, Hwang, Jimmy, Marshall, John L., Urso, Christina E., Wang, Yiru, Ramos, Corinne, Steadman, Kenneth, Pishvaian, Michael J.
Publicado no Cancer (2015)

Safety and efficacy of immune checkpoint inhibitors (ICIs) in cancer patients with HIV, hepatitis B, or hepatitis C viral infection

Por Shah, Neil J., Al-Shbool, Ghassan, Blackburn, Matthew, Cook, Michael, Belouali, Anas, Liu, Stephen V., Madhavan, Subha, He, Aiwu Ruth, Atkins, Michael B., Gibney, Geoffrey T., Kim, Chul
Publicado no J Immunother Cancer (2019)

Hepatic stem cells and transforming growth factor β in hepatocellular carcinoma

Por Majumdar, Avijit, Curley, Steven A., Wu, Xifeng, Brown, Powel, Hwang, Jessica P., Shetty, Kirti, Yao, Zhi-Xing, He, Aiwu Ruth, Li, Shulin, Katz, Lior, Farci, Patrizia, Mishra, Lopa
Publicado em 2012